S&P 500   5,034.15 (+0.24%)
DOW   37,973.57 (+0.58%)
QQQ   425.85 (+0.00%)
AAPL   167.43 (-0.34%)
MSFT   407.65 (-1.02%)
META   504.01 (+1.99%)
GOOGL   155.10 (-0.24%)
AMZN   180.29 (-0.55%)
TSLA   149.30 (-3.96%)
NVDA   842.72 (+0.28%)
AMD   154.34 (+0.21%)
NIO   3.93 (+0.51%)
BABA   69.31 (+0.71%)
T   16.12 (+0.00%)
F   12.06 (+0.17%)
MU   117.44 (+0.95%)
GE   157.65 (+1.27%)
CGC   6.88 (+6.01%)
DIS   113.02 (+0.07%)
AMC   2.77 (-7.05%)
PFE   25.41 (-0.04%)
PYPL   62.99 (-0.43%)
XOM   118.99 (+0.30%)
S&P 500   5,034.15 (+0.24%)
DOW   37,973.57 (+0.58%)
QQQ   425.85 (+0.00%)
AAPL   167.43 (-0.34%)
MSFT   407.65 (-1.02%)
META   504.01 (+1.99%)
GOOGL   155.10 (-0.24%)
AMZN   180.29 (-0.55%)
TSLA   149.30 (-3.96%)
NVDA   842.72 (+0.28%)
AMD   154.34 (+0.21%)
NIO   3.93 (+0.51%)
BABA   69.31 (+0.71%)
T   16.12 (+0.00%)
F   12.06 (+0.17%)
MU   117.44 (+0.95%)
GE   157.65 (+1.27%)
CGC   6.88 (+6.01%)
DIS   113.02 (+0.07%)
AMC   2.77 (-7.05%)
PFE   25.41 (-0.04%)
PYPL   62.99 (-0.43%)
XOM   118.99 (+0.30%)
S&P 500   5,034.15 (+0.24%)
DOW   37,973.57 (+0.58%)
QQQ   425.85 (+0.00%)
AAPL   167.43 (-0.34%)
MSFT   407.65 (-1.02%)
META   504.01 (+1.99%)
GOOGL   155.10 (-0.24%)
AMZN   180.29 (-0.55%)
TSLA   149.30 (-3.96%)
NVDA   842.72 (+0.28%)
AMD   154.34 (+0.21%)
NIO   3.93 (+0.51%)
BABA   69.31 (+0.71%)
T   16.12 (+0.00%)
F   12.06 (+0.17%)
MU   117.44 (+0.95%)
GE   157.65 (+1.27%)
CGC   6.88 (+6.01%)
DIS   113.02 (+0.07%)
AMC   2.77 (-7.05%)
PFE   25.41 (-0.04%)
PYPL   62.99 (-0.43%)
XOM   118.99 (+0.30%)
S&P 500   5,034.15 (+0.24%)
DOW   37,973.57 (+0.58%)
QQQ   425.85 (+0.00%)
AAPL   167.43 (-0.34%)
MSFT   407.65 (-1.02%)
META   504.01 (+1.99%)
GOOGL   155.10 (-0.24%)
AMZN   180.29 (-0.55%)
TSLA   149.30 (-3.96%)
NVDA   842.72 (+0.28%)
AMD   154.34 (+0.21%)
NIO   3.93 (+0.51%)
BABA   69.31 (+0.71%)
T   16.12 (+0.00%)
F   12.06 (+0.17%)
MU   117.44 (+0.95%)
GE   157.65 (+1.27%)
CGC   6.88 (+6.01%)
DIS   113.02 (+0.07%)
AMC   2.77 (-7.05%)
PFE   25.41 (-0.04%)
PYPL   62.99 (-0.43%)
XOM   118.99 (+0.30%)

Ocular Therapeutix (OCUL) SEC Filings & 10K Form

$6.75
-0.83 (-10.95%)
(As of 10:16 AM ET)

Recent Ocular Therapeutix SEC Filings

DateFilerForm TypeView
03/29/2024
4:11 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:23 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
3:43 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:02 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:04 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:06 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:07 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:00 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:34 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:48 PM
Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G/A
02/06/2024
5:35 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:38 PM
Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:26 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:29 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:32 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:41 PM
Ocular Therapeutix (Subject)
White Christopher G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:33 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:36 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:39 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
6:00 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:01 PM
Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:01 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:02 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:03 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:34 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:36 PM
Ocular Therapeutix (Subject)
White Christopher G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:39 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:41 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:31 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
01/25/2024
7:04 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:17 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
12/22/2023
3:04 PM
Deep Track Capital, LP (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
12/18/2023
3:52 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:52 PM
Ocular Therapeutix (Subject)
SUMMER ROAD LLC (Filed by)
Form SC 13D/A
12/14/2023
3:09 PM
Ocular Therapeutix (Filer)
Form 424B5
12/14/2023
7:46 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
11:15 PM
Ocular Therapeutix (Filer)
Form EFFECT
11/07/2023
4:06 PM
Ocular Therapeutix (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/04/2023
8:02 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
6:07 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
IRS Loophole Gives Americans An Escape From Inflation (Ad)

In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.

Request your info kit on gold now
09/05/2023
7:27 AM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
7:45 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
4:18 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/12/2023
4:18 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
7:31 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
7:00 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:28 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
6:02 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:03 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:05 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:05 PM
Ocular Therapeutix (Issuer)
RAINES MERILEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:08 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:09 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:21 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
5:17 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
3:16 PM
Ocular Therapeutix (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OCUL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners